CRC Tier 1 - Determining why mutations of the metabolic enzyme isocitrate dehydrogenase cause leukemias and brain cancers

Daniel Fowler

Combination Gene Therapy and Th1/Th2 Therapy

Leukaemia

Hematology and hematologic malignancies

Hanyang Lin

Identification of new microRNA biomarkers and candidate target genes in primitive CML cells using global comparative RNA analyses

Leukaemia

Katherine Warren

Preclinical Evaluation of Novel Therapeutics for CNS Tumor Therapy

Brain, nervous system

Jon C Aster

Oncogenic Notch Signaling

Leukaemia

Hematology and hematologic malignancies Pathology

Peter Aplan

Collaborative Pathways that Lead to Leukemia

Leukaemia

Pathology Hematology and hematologic malignancies

Jeffrey S Miller

Viral priming and targeting NK cells against solid tumor malignancies

Leukaemia

Hematology and hematologic malignancies

Aaron David Schimmer

Targeting the mitochondrial proteasome, ClpP, in AML

Leukaemia

Seth J Corey

Genetic Modifiers for Cancer Stem Cells in Secondary MDS/AML

Leukaemia

Pediatric oncology or childhood cancer Hematology and hematologic malignancies

Monica J Justice

The Pluripotency Regulator Prdm14 Initiates Cancer by Epigenetic Mechanisms

Leukaemia

Pathology Hematology and hematologic malignancies